albuterol has been researched along with Arrhythmia in 47 studies
Albuterol: A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol.
albuterol : A member of the class of phenylethanolamines that is 4-(2-amino-1-hydroxyethyl)-2-(hydroxymethyl)phenol having a tert-butyl group attached to the nirogen atom. It acts as a beta-adrenergic agonist used in the treatment of asthma and chronic obstructive pulmonary disease (COPD).
| Excerpt | Relevance | Reference |
|---|---|---|
| "To determine whether initiation of salmeterol and fluticasone propionate treatment together improves asthma control greater than initiation of monotherapy with the individual agents alone with no additional safety risk in patients with asthma who had not previously been treated with inhaled corticosteroids." | 9.09 | Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. ( Chervinsky, P; Gross, G; Pearlman, DS; Prillaman, B; Shah, T; Stricker, W; Weinstein, S; Woodring, A, 1999) |
| "Twenty asthmatic patients clinically free of heart disease were studied for the possible arrhythmogenic action of albuterol (salbutamol)." | 9.06 | Asthma, cardiac arrhythmias, and albuterol aerosol. ( Lazzari, JO; Martelli, NA; Raimondi, AC, 1986) |
| "We compared the frequency and severity of cardiac arrhythmias during combined oral theophylline and inhaled salbutamol vs." | 9.06 | Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. ( Huikuri, H; Korhonen, UR; Linnaluoto, M; Poukkula, A, 1989) |
| "A retrospective, case-controlled analysis comparing patients admitted to a medical intensive care unit with severe exacerbations of asthma who received continuously nebulized albuterol (CNA) versus intermittent albuterol (INA) treatments is reported." | 7.69 | Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study. ( Baker, EK; Marinac, JS; Salzman, GA; Willsie, SK, 1997) |
| "Hemodynamic alterations were studied to determine their role in isoproterenol-induced cardiac arrhythmias in the desoxycorticosterone acetate--saline-treat rat." | 7.66 | Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats. ( Barletta, MA; Guideri, G; Lehr, D, 1978) |
| "In critically ill adult patients, nebulized albuterol and ipratropium does not cause significant tachycardia or tachyarrhythmias." | 5.15 | Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients. ( Barber, KR; Khorfan, FM; Smith, P; Watt, S, 2011) |
| "To determine whether initiation of salmeterol and fluticasone propionate treatment together improves asthma control greater than initiation of monotherapy with the individual agents alone with no additional safety risk in patients with asthma who had not previously been treated with inhaled corticosteroids." | 5.09 | Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma. ( Chervinsky, P; Gross, G; Pearlman, DS; Prillaman, B; Shah, T; Stricker, W; Weinstein, S; Woodring, A, 1999) |
| "Twenty asthmatic patients clinically free of heart disease were studied for the possible arrhythmogenic action of albuterol (salbutamol)." | 5.06 | Asthma, cardiac arrhythmias, and albuterol aerosol. ( Lazzari, JO; Martelli, NA; Raimondi, AC, 1986) |
| "We compared the frequency and severity of cardiac arrhythmias during combined oral theophylline and inhaled salbutamol vs." | 5.06 | Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias. ( Huikuri, H; Korhonen, UR; Linnaluoto, M; Poukkula, A, 1989) |
| " We assessed characteristics associated with continuous albuterol therapy and, for those treated, duration of therapy and the proportion who clinically deteriorated (ICU transfer or progression to enhanced respiratory support) or who were identified as having hypokalemia or an arrhythmia." | 3.80 | Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting. ( Fieldston, ES; Kenyon, CC; Keren, R; Luan, X; Zorc, JJ, 2014) |
| "A retrospective, case-controlled analysis comparing patients admitted to a medical intensive care unit with severe exacerbations of asthma who received continuously nebulized albuterol (CNA) versus intermittent albuterol (INA) treatments is reported." | 3.69 | Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study. ( Baker, EK; Marinac, JS; Salzman, GA; Willsie, SK, 1997) |
| "Arrhythmia was induced by the investigated drugs, injected intravenously: adrenaline (ADR); noradrenaline (NA); phenylephrine (PE); isoprenaline (IP); terbutaline (Tb) and salbutamol (Sb)." | 3.68 | Sympathomimetic amines and cardiac arrhythmias. ( Akavia, E; Korczyn, AD; Oppenheimer, E; Shavit, S, 1990) |
| "Hemodynamic alterations were studied to determine their role in isoproterenol-induced cardiac arrhythmias in the desoxycorticosterone acetate--saline-treat rat." | 3.66 | Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats. ( Barletta, MA; Guideri, G; Lehr, D, 1978) |
| "Hypokalemia and arrhythmias (particularly ventricular arrhythmias) are potential complications." | 2.82 | Retrospective evaluation of acute salbutamol (albuterol) exposure in dogs: 501 cases. ( Bates, N; Crouchley, J, 2022) |
| "In conclusion, in this large cohort of COPD patients with no or stable cardiac comorbidities, a high proportion ( approximately 40%) of patients were observed to have atrial tachycardia before treatment, which increased by 2%-5% with LABA treatment." | 2.73 | Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol. ( Baumgartner, RA; Cheng, H; Grogan, DR; Hanrahan, JP; Morganroth, J; Wilson, A; Zimetbaum, PJ, 2008) |
| " The frequency of adverse events, COPD exacerbations, and use of short-acting bronchodilator agents were assessed throughout the study period." | 2.73 | Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance. ( Baumgartner, RA; Donohue, JF; Goodwin, E; Grogan, DR; Hanania, NA; Hanrahan, JP; Sciarappa, KA, 2008) |
| "Supraventricular arrhythmias were common on both saline and salbutamol days (8 vs." | 2.67 | Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study. ( Hall, IP; Johnston, ID; Woodhead, MA, 1994) |
| "It is likely that arrhythmias may be precipitated in patients with hypoxaemia, acidosis or those with preexisting cardiovascular disease." | 2.66 | Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease. ( Burgess, CD; Crane, J; Graham, AN; Maling, TJ, 1987) |
| "Patients with COPD and a similar age, FEV1 and PaO2 who required no hospital care during the study year (1998) were randomly selected as controls." | 1.32 | Risk factors of emergency care and admissions in COPD patients with high consumption of health resources. ( Martínez, MA; Perpiñá, M; Román, P; Sánchez, L; Soler, JJ, 2004) |
| "No arrhythmia was seen during the hypokalaemic phase." | 1.29 | The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential. ( Brandt, HD; Du Plooy, WJ; Hay, L; Kahler, CP; Schutte, PJ, 1994) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 19 (40.43) | 18.7374 |
| 1990's | 16 (34.04) | 18.2507 |
| 2000's | 5 (10.64) | 29.6817 |
| 2010's | 6 (12.77) | 24.3611 |
| 2020's | 1 (2.13) | 2.80 |
| Authors | Studies |
|---|---|
| Crouchley, J | 1 |
| Bates, N | 1 |
| Maxwell, AP | 1 |
| Linden, K | 1 |
| O'Donnell, S | 1 |
| Hamilton, PK | 1 |
| McVeigh, GE | 1 |
| Kenyon, CC | 1 |
| Fieldston, ES | 1 |
| Luan, X | 1 |
| Keren, R | 1 |
| Zorc, JJ | 1 |
| Wang, Y | 1 |
| Yuan, J | 1 |
| Qian, Z | 1 |
| Zhang, X | 1 |
| Chen, Y | 1 |
| Hou, X | 1 |
| Zou, J | 1 |
| Hanrahan, JP | 2 |
| Grogan, DR | 2 |
| Baumgartner, RA | 2 |
| Wilson, A | 1 |
| Cheng, H | 1 |
| Zimetbaum, PJ | 1 |
| Morganroth, J | 1 |
| Donohue, JF | 1 |
| Hanania, NA | 1 |
| Sciarappa, KA | 1 |
| Goodwin, E | 1 |
| Płusa, T | 1 |
| Khorfan, FM | 1 |
| Smith, P | 1 |
| Watt, S | 1 |
| Barber, KR | 1 |
| Manthous, CA | 1 |
| Soler, JJ | 1 |
| Sánchez, L | 1 |
| Román, P | 1 |
| Martínez, MA | 1 |
| Perpiñá, M | 1 |
| Canepa-Anson, R | 1 |
| Dawson, JR | 1 |
| Frankl, WS | 1 |
| Kuan, P | 1 |
| Sutton, GC | 1 |
| Reuben, S | 1 |
| Poole-Wilson, PA | 1 |
| Al-Hillawi, AH | 1 |
| Hayward, R | 1 |
| Johnson, NM | 1 |
| Harrison, P | 1 |
| Thiessen, B | 1 |
| Pedersen, OF | 1 |
| Crawford, SM | 1 |
| Miles, DW | 1 |
| Tandon, MK | 1 |
| Cukier, A | 1 |
| Vargas, FS | 1 |
| Teixeira, LR | 1 |
| Grupi, CJ | 1 |
| Terra-Filho, M | 1 |
| Carvalho-Pinto, RM | 1 |
| Light, RW | 1 |
| Hall, IP | 1 |
| Woodhead, MA | 1 |
| Johnston, ID | 1 |
| Du Plooy, WJ | 1 |
| Hay, L | 1 |
| Kahler, CP | 1 |
| Schutte, PJ | 1 |
| Brandt, HD | 1 |
| Malerba, M | 2 |
| Politi, A | 2 |
| Filippi, B | 2 |
| Boni, E | 1 |
| Grassi, V | 2 |
| Bonnin, AJ | 1 |
| Richmond, GW | 1 |
| Musto, PK | 1 |
| Volgman, AS | 1 |
| Moy, JN | 1 |
| Kakhnovskiĭ, IM | 1 |
| Marinin, VF | 1 |
| Sorokina, LA | 1 |
| Markova, ZS | 1 |
| Semmekrot, BA | 1 |
| Monnens, LA | 1 |
| Baker, EK | 1 |
| Willsie, SK | 1 |
| Marinac, JS | 1 |
| Salzman, GA | 1 |
| Rossinen, J | 1 |
| Partanen, J | 1 |
| Stenius-Aarniala, B | 1 |
| Nieminen, MS | 1 |
| Cazzola, M | 2 |
| Imperatore, F | 1 |
| Salzillo, A | 1 |
| Di Perna, F | 1 |
| Calderaro, F | 2 |
| Imperatore, A | 1 |
| Matera, MG | 2 |
| Califano, C | 1 |
| Di Pema, F | 1 |
| Vinciguerra, A | 1 |
| Donner, CF | 1 |
| Pearlman, DS | 1 |
| Stricker, W | 1 |
| Weinstein, S | 1 |
| Gross, G | 1 |
| Chervinsky, P | 1 |
| Woodring, A | 1 |
| Prillaman, B | 1 |
| Shah, T | 1 |
| Zimmer, B | 1 |
| Casson, AC | 1 |
| Bayliff, CD | 1 |
| George, CF | 1 |
| Coskun, S | 2 |
| Yuksel, H | 2 |
| Tikiz, H | 1 |
| Danahaliloğlu, S | 1 |
| Polat, M | 1 |
| Onag, A | 1 |
| Mancini, G | 1 |
| Mannino, F | 2 |
| Larsson, S | 1 |
| Mariotta, S | 1 |
| Pasqua, F | 1 |
| Barletta, MA | 1 |
| Lehr, D | 1 |
| Guideri, G | 1 |
| Deacon, SP | 1 |
| Del Torre, L | 1 |
| Fiore, G | 1 |
| Macluso, S | 1 |
| Pesce, L | 1 |
| Zambruni, U | 1 |
| Oppenheimer, E | 1 |
| Akavia, E | 1 |
| Shavit, S | 1 |
| Korczyn, AD | 1 |
| Rotstein, Z | 1 |
| Battler, A | 1 |
| Rath, S | 1 |
| Perek, J | 1 |
| Eldar, M | 1 |
| Martelli, NA | 1 |
| Raimondi, AC | 1 |
| Lazzari, JO | 1 |
| Kotoujansky, J | 1 |
| Langer, B | 1 |
| Brechenmacher, C | 1 |
| Schlaeder, G | 1 |
| Lim, R | 1 |
| Walshaw, MJ | 1 |
| Saltissi, S | 1 |
| Hind, CR | 1 |
| Poukkula, A | 1 |
| Korhonen, UR | 1 |
| Huikuri, H | 1 |
| Linnaluoto, M | 1 |
| Crane, J | 1 |
| Burgess, CD | 1 |
| Graham, AN | 1 |
| Maling, TJ | 1 |
| Mettauer, B | 1 |
| Rouleau, JL | 1 |
| Burgess, JH | 1 |
| Tekeres, M | 1 |
| Mezey, B | 1 |
| Kellényi, L | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Prospective Trial of Effect of Nebulized Bronchodilators on Heart Rate and Arrhythmias in Critically Ill Adult Patients[NCT01151579] | Phase 4 | 89 participants (Actual) | Interventional | 2008-12-31 | Completed | ||
| A 12-week, Double-blind, Multicenter, 3-crossover, Placebo Controlled and Randomized Trial to Investigate the Efficacy and Safety of 10mg and 5mg Bambuterol Tablets Once Daily in Patients With Chronic Obstructive Pulmonary Disease (COPD)[NCT01796730] | Phase 4 | 60 participants (Actual) | Interventional | 2013-02-28 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Any new arrhythmia documented in the medical record that occurred between breathing treatments. (NCT01151579)
Timeframe: 15 minutes after each treatment for average of 3 to 5 days
| Intervention | percent (Number) |
|---|---|
| Nebulized Albuterol 2.5mg | 0.33 |
| Levalbuterol 1.25 | 1.3 |
Average difference in Heart rate between pre and post breathing treatments (NCT01151579)
Timeframe: Five days
| Intervention | bpm (Mean) |
|---|---|
| Nebulized Albuterol 2.5mg | -0.16 |
| Levalbuterol 1.25 | 1.40 |
Documented new arrhythmia occurring during study. (NCT01151579)
Timeframe: Five days
| Intervention | participants (Number) |
|---|---|
| Nebulized Albuterol 2.5mg | 2 |
| Levalbuterol 1.25 | 3 |
4 reviews available for albuterol and Arrhythmia
| Article | Year |
|---|---|
Retrospective evaluation of acute salbutamol (albuterol) exposure in dogs: 501 cases.
Topics: Albuterol; Animals; Arrhythmias, Cardiac; Dog Diseases; Dogs; Hypokalemia; Potassium; Retrospective | 2022 |
Management of hyperkalaemia.
Topics: Albuterol; Arrhythmias, Cardiac; Drug Therapy, Combination; Emergency Treatment; Glucose; Humans; Hy | 2013 |
Beta 2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias.
Topics: Adrenergic beta-Agonists; Albuterol; Arrhythmias, Cardiac; Blood Glucose; Epinephrine; Ethanolamines | 1982 |
Long-term treatment with beta2-adrenostimulants in asthma. Side effects, selectivity, tolerance, and routes of administration.
Topics: Administration, Oral; Adrenergic beta-Agonists; Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; E | 1977 |
17 trials available for albuterol and Arrhythmia
| Article | Year |
|---|---|
Arrhythmias in patients with chronic obstructive pulmonary disease (COPD): occurrence frequency and the effect of treatment with the inhaled long-acting beta2-agonists arformoterol and salmeterol.
Topics: Administration, Inhalation; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Aged; Alb | 2008 |
Arformoterol and salmeterol in the treatment of chronic obstructive pulmonary disease: a one year evaluation of safety and tolerance.
Topics: Albuterol; Arrhythmias, Cardiac; Bronchitis; Bronchodilator Agents; Ethanolamines; Female; Forced Ex | 2008 |
Effects of nebulized bronchodilator therapy on heart rate and arrhythmias in critically ill adult patients.
Topics: Administration, Inhalation; Adult; Aged; Aged, 80 and over; Albuterol; Analysis of Variance; Arrhyth | 2011 |
Incidence of cardiac arrhythmias in patients taking slow release salbutamol and slow release terbutaline for asthma.
Topics: Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Delayed-Action Preparations; Female; Humans; Male; M | 1984 |
Effect of freon inhalation on maximal expiratoryflows and heart rhythm after treatment with salbutamol and ipratropium bromide.
Topics: Adult; Aerosol Propellants; Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; Atropine Derivatives; | 1980 |
Arrhythmogenic effects of combined orally administered theophylline and albuterol in patients with chronic obstructive pulmonary disease.
Topics: Administration, Oral; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Drug Therapy, Co | 1994 |
Effect of high-dose salbutamol on cardiac rhythm in severe chronic airflow obstruction: a controlled study.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Carbon Dioxide; Electrocardiography, Ambulatory; Female; Forc | 1994 |
Cardiac effects of formoterol and salmeterol in patients suffering from COPD with preexisting cardiac arrhythmias and hypoxemia.
Topics: Administration, Inhalation; Adrenergic beta-Agonists; Aged; Albuterol; Arrhythmias, Cardiac; Cross-O | 1998 |
Oral bambuterol compared to inhaled salmeterol in patients with partially reversible chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Administration, Oral; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Bron | 1999 |
Inhaled salmeterol and fluticasone: a study comparing monotherapy and combination therapy in asthma.
Topics: Adolescent; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adult; Albuterol; Androst | 1999 |
Standard dose of inhaled albuterol significantly increases QT dispersion compared to low dose of albuterol plus ipratropium bromide therapy in moderate to severe acute asthma attacks in children.
Topics: Acute Disease; Administration, Inhalation; Adolescent; Albuterol; Arrhythmias, Cardiac; Asthma; Bron | 2001 |
Lower arrythmogenic risk of low dose albuterol plus ipratropium.
Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Bronchodilator Agents; Female; Humans; Infant; Ipratropium; | 2001 |
[Intravenous salbutamol in the treatment of bronchial spasm].
Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Bronchial Spasm; Clinical Trials as Topic; Drug Evaluatio | 1978 |
[Changes in the heart rhythm and slow-release beta-2 agonist therapy (peroral) in asthmatic patients. A Holter study].
Topics: Administration, Oral; Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Delayed-Action Preparations; E | 1992 |
Asthma, cardiac arrhythmias, and albuterol aerosol.
Topics: Adult; Aerosols; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Cardiac Complexes, Premature; Clinic | 1986 |
Theophylline and salbutamol in combination in patients with obstructive pulmonary disease and concurrent heart disease: effect on cardiac arrhythmias.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Clinical Trials as Topic; Delayed-Action Preparations; Drug T | 1989 |
Hypokalaemic and electrocardiographic effects of aminophylline and salbutamol in obstructive airways disease.
Topics: Administration, Inhalation; Adult; Albuterol; Aminophylline; Arrhythmias, Cardiac; Asthma; Clinical | 1987 |
26 other studies available for albuterol and Arrhythmia
| Article | Year |
|---|---|
Safety and effectiveness of continuous aerosolized albuterol in the non-intensive care setting.
Topics: Adolescent; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Child; Child, Preschool; Cohort | 2014 |
β2 adrenergic receptor activation governs cardiac repolarization and arrhythmogenesis in a guinea pig model of heart failure.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Amrinone; Animals; Arrhythmias, Ca | 2015 |
[Agonists of beta2 adrenergic receptor in the therapy of obstructive diseases].
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Albuterol; Arrhythmias, Cardiac; Card | 2010 |
Aerosols and details.
Topics: Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Female; Heart Rate; Humans; Ipratropium; Mal | 2012 |
Risk factors of emergency care and admissions in COPD patients with high consumption of health resources.
Topics: Administration, Inhalation; Aged; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Case-Contr | 2004 |
Incidence of cardiac arrhythmias in patients taking slow release salbutamol and terbutaline for asthma.
Topics: Adult; Albuterol; Arrhythmias, Cardiac; Humans; Middle Aged; Terbutaline | 1984 |
Salbutamol and cardiac arrhythmias.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Electrocardiography; Female; Heart Rate; Humans; Infusions, P | 1981 |
Cardiopulmonary effects of fenoterol and salbutamol aerosols.
Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Dose-Response Relationship, Drug; | 1980 |
The dose-related hyper-and-hypokalaemic effects of salbutamol and its arrhythmogenic potential.
Topics: Albuterol; Animals; Arrhythmias, Cardiac; Blood Pressure; Dose-Response Relationship, Drug; Electroc | 1994 |
Controlled-release oral salbutamol and cardiac arrhythmias in asthmatic patients.
Topics: Administration, Oral; Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Delayed-Action Preparations; F | 1993 |
Repeated inhalation of nebulized albuterol did not induce arrhythmias in a patient with Wolff-Parkinson-White syndrome and asthma.
Topics: Administration, Inhalation; Adult; Albuterol; Arrhythmias, Cardiac; Asthma; Contraindications; Elect | 1993 |
[Cardiac monitoring in bronchial asthma patients taking salben].
Topics: Administration, Inhalation; Adult; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Bronchodilator Age | 1996 |
A warning for the treatment of hyperkalaemia with salbutamol.
Topics: Adrenergic beta-Agonists; Albuterol; Animals; Arrhythmias, Cardiac; Child; Humans; Hyperkalemia; Pap | 1997 |
Continuously nebulized albuterol in severe exacerbations of asthma in adults: a case-controlled study.
Topics: Administration, Inhalation; Adolescent; Adrenergic beta-Agonists; Adult; Aged; Albuterol; Arrhythmia | 1997 |
Salbutamol inhalation has no effect on myocardial ischaemia, arrhythmias and heart-rate variability in patients with coronary artery disease plus asthma or chronic obstructive pulmonary disease.
Topics: Administration, Inhalation; Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Bronchodi | 1998 |
The clinical effects and cost-avoidance of a change in perioperative bronchodilator use.
Topics: Aerosols; Albuterol; Arrhythmias, Cardiac; Bronchodilator Agents; Cost Savings; Drug Costs; Drug Uti | 1994 |
[Side-effects of beta-adrenergic drugs].
Topics: Adrenergic beta-Agonists; Albuterol; Angina Pectoris; Arrhythmias, Cardiac; Headache; Humans; Hypert | 1976 |
Hemodynamic alterations in isoproterenol-induced cardiac arrhythmias in corticoid-treated rats.
Topics: Adrenal Cortex Hormones; Albuterol; Animals; Arrhythmias, Cardiac; Blood Pressure; Desoxycorticoster | 1978 |
Metabolic effects of salbutamol.
Topics: Albuterol; Arrhythmias, Cardiac; Humans | 1977 |
[Salbutamol therapy of chronic bronchopathic patients with cardiac arrhythmias].
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Asthma; Chronic Disease; Female; Heart Rate; Humans; Lung Dis | 1976 |
Sympathomimetic amines and cardiac arrhythmias.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Albuterol; Animals; Arrhythmias, Cardiac; | 1990 |
Acute hemodynamic and arrhythmogenic effects of high-dose intravenous salbutamol in patients with chronic left ventricular dysfunction.
Topics: Adult; Aged; Albuterol; Arrhythmias, Cardiac; Cardiac Output; Electrocardiography, Ambulatory; Femal | 1990 |
[Tocolysis using salbutamol in cases of cardiac rhythm disorders in the mother. Apropos of 4 cases].
Topics: Adult; Albuterol; Arrhythmias, Cardiac; Cardiac Complexes, Premature; Female; Humans; Labor, Induced | 1985 |
Cardiac arrhythmias during acute exacerbations of chronic airflow limitation: effect of fall in plasma potassium concentration induced by nebulised beta 2-agonist therapy.
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Albuterol; Arrhythmias, Cardiac; Asthma; Humans; Male | 1989 |
Detrimental arrhythmogenic and sustained beneficial hemodynamic effects of oral salbutamol in patients with chronic congestive heart failure.
Topics: Aged; Albuterol; Arrhythmias, Cardiac; Blood Pressure; Cardiac Output; Electrocardiography; Female; | 1985 |
Effect of beta receptor-stimulating drugs on the cardiovascular and respiratory function of critically ill patients with serious heart disorders.
Topics: Albuterol; Arrhythmias, Cardiac; Asthma; Blood Pressure; Cardiovascular System; Female; Heart; Heart | 1974 |